Valex Syrup 200 mg/5 ml is a liquid oral formulation of Sodium Valproate, designed for the treatment of epilepsy, bipolar disorder, and migraine prophylaxis, particularly for children or patients who have difficulty swallowing tablets. Sodium Valproate is a broad-spectrum antiepileptic drug that works by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby stabilizing neuronal activity and preventing seizures.
Valex Syrup offers accurate dosing, ease of administration, and flexibility, making it suitable for pediatric patients and for situations requiring adjustable dose titration. The syrup formulation ensures better compliance in patients who are unable to take solid oral dosage forms.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Primary Anti-Epileptic Drugs
Valex Syrup 200 mg/5 ml is indicated for:
Epilepsy:
Partial seizures
Absence seizures (petit mal)
Generalized tonic-clonic seizures (grand mal)
Myoclonic seizures
Atonic seizures
Mixed seizures including absence attacks
Prophylaxis of febrile convulsions
Prophylaxis of post-traumatic epilepsy
Bipolar disorder (mood stabilization)
Prophylaxis of migraine
The syrup is particularly useful in children, allowing precise weight-based dosing and easy administration.
Sodium Valproate enhances GABAergic neurotransmission in the brain, which increases inhibitory activity and stabilizes electrical activity, reducing the frequency and severity of seizures.
Mechanism of Action:
Increases brain levels of GABA, the primary inhibitory neurotransmitter
Reduces neuronal hyperexcitability
Controls seizures across multiple types of epilepsy
Pharmacokinetics:
Well absorbed orally; peak plasma concentrations achieved within 1–4 hours
Metabolized in the liver; partially excreted in urine
Half-life: 9–16 hours in adults, shorter in children
Adults:
Initial: 600 mg/day in 2 divided doses after food
Titration: Increase by 200 mg/day every 3 days as needed
Maintenance: 1–2 g/day (20–30 mg/kg/day), up to 2.5 g/day
Children:
Up to 20 kg: 20 mg/kg/day in divided doses
Over 20 kg: Initial 400 mg/day, titrated to 20–35 mg/kg/day
Febrile convulsions: 20–30 mg/kg/day in 3 divided doses
Administration Tips:
Shake the bottle well before use
Measure the dose using a calibrated measuring device
Administer after meals to reduce gastrointestinal discomfort
Valex Syrup can inhibit drug metabolism, affecting:
Phenobarbital
Phenytoin
Warfarin
Aspirin
Close monitoring is recommended to avoid adverse effects or toxicity.
Known hypersensitivity to Sodium Valproate
Liver dysfunction
Pregnancy or women of childbearing potential, unless clearly indicated
Gastrointestinal: nausea, vomiting, anorexia
CNS: sedation, tremor, ataxia
Dermatologic: rash, alopecia
Rare: hepatic injury, pancreatitis, hyperammonemia
Routine monitoring of liver function and plasma levels is recommended, especially in young children or those on multiple antiepileptic drugs.
Avoid sudden withdrawal to prevent seizures
Monitor liver function, especially in children under 2 years
Adjust dose in renal impairment
Avoid use in systemic lupus erythematosus
Crosses the placenta; associated with neural tube defects if exposed in the first trimester
Excreted in breast milk; caution advised
Store below 30°C, protected from light
Keep out of reach of children
Valex Syrup increases GABA activity in the brain, enhancing inhibitory neurotransmission, which stabilizes neuronal firing and controls various types of seizures effectively.
Login Or Registerto submit your questions to seller
No none asked to seller yet